nodes	percent_of_prediction	percent_of_DWPC	metapath
Eprosartan—CYP2C9—brain cancer	0.734	1	CbGaD
Eprosartan—ABCC2—Carboplatin—brain cancer	0.0896	0.544	CbGbCtD
Eprosartan—ABCC2—Etoposide—brain cancer	0.0752	0.456	CbGbCtD
Eprosartan—Losartan—CYP2C9—brain cancer	0.00179	1	CrCbGaD
Eprosartan—Otitis media—Temozolomide—brain cancer	0.000966	0.00972	CcSEcCtD
Eprosartan—Visual impairment—Lomustine—brain cancer	0.000948	0.00954	CcSEcCtD
Eprosartan—Purpura—Procarbazine—brain cancer	0.000937	0.00942	CcSEcCtD
Eprosartan—Rigors—Temozolomide—brain cancer	0.000921	0.00927	CcSEcCtD
Eprosartan—Rash maculo-papular—Hydroxyurea—brain cancer	0.000875	0.0088	CcSEcCtD
Eprosartan—Ataxia—Procarbazine—brain cancer	0.000849	0.00854	CcSEcCtD
Eprosartan—Viral infection—Temozolomide—brain cancer	0.000833	0.00838	CcSEcCtD
Eprosartan—Herpes simplex—Temozolomide—brain cancer	0.000816	0.00821	CcSEcCtD
Eprosartan—Angina pectoris—Procarbazine—brain cancer	0.00076	0.00765	CcSEcCtD
Eprosartan—Sweating increased—Procarbazine—brain cancer	0.00076	0.00765	CcSEcCtD
Eprosartan—Urinary incontinence—Carmustine—brain cancer	0.000752	0.00756	CcSEcCtD
Eprosartan—Rigors—Etoposide—brain cancer	0.000737	0.00741	CcSEcCtD
Eprosartan—Influenza like illness—Temozolomide—brain cancer	0.000731	0.00735	CcSEcCtD
Eprosartan—Urinary incontinence—Temozolomide—brain cancer	0.000726	0.0073	CcSEcCtD
Eprosartan—Pollakiuria—Procarbazine—brain cancer	0.000721	0.00725	CcSEcCtD
Eprosartan—Thrombocytopenia—Lomustine—brain cancer	0.000685	0.00688	CcSEcCtD
Eprosartan—Pain—Carboplatin—brain cancer	0.000683	0.00687	CcSEcCtD
Eprosartan—Neuropathy peripheral—Procarbazine—brain cancer	0.000682	0.00686	CcSEcCtD
Eprosartan—Abnormal vision—Carmustine—brain cancer	0.000679	0.00683	CcSEcCtD
Eprosartan—Face oedema—Hydroxyurea—brain cancer	0.000675	0.00679	CcSEcCtD
Eprosartan—Anorexia—Lomustine—brain cancer	0.000666	0.0067	CcSEcCtD
Eprosartan—Haematuria—Procarbazine—brain cancer	0.000664	0.00667	CcSEcCtD
Eprosartan—Epistaxis—Procarbazine—brain cancer	0.000656	0.0066	CcSEcCtD
Eprosartan—Abnormal vision—Temozolomide—brain cancer	0.000656	0.0066	CcSEcCtD
Eprosartan—Blood creatinine increased—Hydroxyurea—brain cancer	0.000655	0.00659	CcSEcCtD
Eprosartan—Diabetes mellitus—Carmustine—brain cancer	0.00065	0.00653	CcSEcCtD
Eprosartan—Swelling—Carmustine—brain cancer	0.000641	0.00644	CcSEcCtD
Eprosartan—Body temperature increased—Carboplatin—brain cancer	0.000632	0.00635	CcSEcCtD
Eprosartan—Gastroenteritis—Temozolomide—brain cancer	0.000616	0.0062	CcSEcCtD
Eprosartan—Vascular purpura—Temozolomide—brain cancer	0.00061	0.00614	CcSEcCtD
Eprosartan—Decreased appetite—Lomustine—brain cancer	0.000608	0.00611	CcSEcCtD
Eprosartan—Hot flush—Temozolomide—brain cancer	0.000584	0.00587	CcSEcCtD
Eprosartan—Menopausal symptoms—Temozolomide—brain cancer	0.000579	0.00582	CcSEcCtD
Eprosartan—Hyponatraemia—Carmustine—brain cancer	0.000567	0.00571	CcSEcCtD
Eprosartan—Purpura—Temozolomide—brain cancer	0.000567	0.0057	CcSEcCtD
Eprosartan—Chills—Procarbazine—brain cancer	0.000561	0.00564	CcSEcCtD
Eprosartan—Body temperature increased—Lomustine—brain cancer	0.000553	0.00556	CcSEcCtD
Eprosartan—Oesophagitis—Etoposide—brain cancer	0.00055	0.00553	CcSEcCtD
Eprosartan—Rash maculo-papular—Etoposide—brain cancer	0.000547	0.0055	CcSEcCtD
Eprosartan—Face oedema—Carmustine—brain cancer	0.000546	0.00549	CcSEcCtD
Eprosartan—Tension—Procarbazine—brain cancer	0.000534	0.00537	CcSEcCtD
Eprosartan—Ataxia—Carmustine—brain cancer	0.000531	0.00534	CcSEcCtD
Eprosartan—Nervousness—Procarbazine—brain cancer	0.000528	0.00531	CcSEcCtD
Eprosartan—Neuropathy peripheral—Hydroxyurea—brain cancer	0.000528	0.00531	CcSEcCtD
Eprosartan—Face oedema—Temozolomide—brain cancer	0.000527	0.0053	CcSEcCtD
Eprosartan—Hypokalaemia—Carmustine—brain cancer	0.000514	0.00517	CcSEcCtD
Eprosartan—Ataxia—Temozolomide—brain cancer	0.000513	0.00516	CcSEcCtD
Eprosartan—Tremor—Procarbazine—brain cancer	0.00051	0.00512	CcSEcCtD
Eprosartan—Muscular weakness—Carmustine—brain cancer	0.000498	0.00501	CcSEcCtD
Eprosartan—Hypokalaemia—Temozolomide—brain cancer	0.000497	0.005	CcSEcCtD
Eprosartan—Swelling—Etoposide—brain cancer	0.000495	0.00498	CcSEcCtD
Eprosartan—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.000492	0.00494	CcSEcCtD
Eprosartan—Syncope—Procarbazine—brain cancer	0.000488	0.00491	CcSEcCtD
Eprosartan—Alanine aminotransferase increased—Temozolomide—brain cancer	0.000482	0.00484	CcSEcCtD
Eprosartan—Muscular weakness—Temozolomide—brain cancer	0.000482	0.00484	CcSEcCtD
Eprosartan—Loss of consciousness—Procarbazine—brain cancer	0.000478	0.00481	CcSEcCtD
Eprosartan—Cough—Procarbazine—brain cancer	0.000475	0.00477	CcSEcCtD
Eprosartan—Arthralgia—Procarbazine—brain cancer	0.000463	0.00466	CcSEcCtD
Eprosartan—Myalgia—Procarbazine—brain cancer	0.000463	0.00466	CcSEcCtD
Eprosartan—Anxiety—Procarbazine—brain cancer	0.000461	0.00464	CcSEcCtD
Eprosartan—Sweating increased—Temozolomide—brain cancer	0.00046	0.00462	CcSEcCtD
Eprosartan—Bronchitis—Temozolomide—brain cancer	0.000454	0.00456	CcSEcCtD
Eprosartan—Dry mouth—Procarbazine—brain cancer	0.000453	0.00455	CcSEcCtD
Eprosartan—Cardiac failure—Etoposide—brain cancer	0.000448	0.0045	CcSEcCtD
Eprosartan—Vomiting—Lomustine—brain cancer	0.000445	0.00447	CcSEcCtD
Eprosartan—Hyperglycaemia—Carmustine—brain cancer	0.000441	0.00443	CcSEcCtD
Eprosartan—Upper respiratory tract infection—Temozolomide—brain cancer	0.000439	0.00441	CcSEcCtD
Eprosartan—Shock—Procarbazine—brain cancer	0.000437	0.00439	CcSEcCtD
Eprosartan—Pollakiuria—Temozolomide—brain cancer	0.000436	0.00438	CcSEcCtD
Eprosartan—Thrombocytopenia—Procarbazine—brain cancer	0.000435	0.00437	CcSEcCtD
Eprosartan—Depression—Carmustine—brain cancer	0.000434	0.00437	CcSEcCtD
Eprosartan—Chills—Hydroxyurea—brain cancer	0.000434	0.00436	CcSEcCtD
Eprosartan—Tachycardia—Procarbazine—brain cancer	0.000433	0.00436	CcSEcCtD
Eprosartan—Hyperhidrosis—Procarbazine—brain cancer	0.000429	0.00432	CcSEcCtD
Eprosartan—Renal failure—Carmustine—brain cancer	0.000428	0.0043	CcSEcCtD
Eprosartan—Neuropathy peripheral—Carmustine—brain cancer	0.000427	0.00429	CcSEcCtD
Eprosartan—Hyperglycaemia—Temozolomide—brain cancer	0.000426	0.00428	CcSEcCtD
Eprosartan—Urinary tract infection—Carmustine—brain cancer	0.000423	0.00426	CcSEcCtD
Eprosartan—Anorexia—Procarbazine—brain cancer	0.000423	0.00426	CcSEcCtD
Eprosartan—Depression—Temozolomide—brain cancer	0.00042	0.00422	CcSEcCtD
Eprosartan—Nausea—Lomustine—brain cancer	0.000415	0.00418	CcSEcCtD
Eprosartan—Hypotension—Procarbazine—brain cancer	0.000415	0.00417	CcSEcCtD
Eprosartan—Neuropathy peripheral—Temozolomide—brain cancer	0.000412	0.00415	CcSEcCtD
Eprosartan—Urinary tract infection—Temozolomide—brain cancer	0.000409	0.00411	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000404	0.00407	CcSEcCtD
Eprosartan—Insomnia—Procarbazine—brain cancer	0.000401	0.00404	CcSEcCtD
Eprosartan—Paraesthesia—Procarbazine—brain cancer	0.000399	0.00401	CcSEcCtD
Eprosartan—Sinusitis—Temozolomide—brain cancer	0.000395	0.00397	CcSEcCtD
Eprosartan—Somnolence—Procarbazine—brain cancer	0.000395	0.00397	CcSEcCtD
Eprosartan—Ill-defined disorder—Hydroxyurea—brain cancer	0.000391	0.00393	CcSEcCtD
Eprosartan—Decreased appetite—Procarbazine—brain cancer	0.000386	0.00388	CcSEcCtD
Eprosartan—Alanine aminotransferase increased—Etoposide—brain cancer	0.000385	0.00388	CcSEcCtD
Eprosartan—Oedema peripheral—Carmustine—brain cancer	0.000385	0.00387	CcSEcCtD
Eprosartan—Fatigue—Procarbazine—brain cancer	0.000383	0.00385	CcSEcCtD
Eprosartan—Malaise—Hydroxyurea—brain cancer	0.00038	0.00382	CcSEcCtD
Eprosartan—Pain—Procarbazine—brain cancer	0.00038	0.00382	CcSEcCtD
Eprosartan—Constipation—Procarbazine—brain cancer	0.00038	0.00382	CcSEcCtD
Eprosartan—Visual impairment—Carmustine—brain cancer	0.000377	0.00379	CcSEcCtD
Eprosartan—Pharyngitis—Temozolomide—brain cancer	0.000375	0.00377	CcSEcCtD
Eprosartan—Oedema peripheral—Temozolomide—brain cancer	0.000372	0.00374	CcSEcCtD
Eprosartan—Sweating increased—Etoposide—brain cancer	0.000368	0.0037	CcSEcCtD
Eprosartan—Feeling abnormal—Procarbazine—brain cancer	0.000366	0.00368	CcSEcCtD
Eprosartan—Visual impairment—Temozolomide—brain cancer	0.000364	0.00366	CcSEcCtD
Eprosartan—Gastrointestinal pain—Procarbazine—brain cancer	0.000363	0.00365	CcSEcCtD
Eprosartan—Discomfort—Hydroxyurea—brain cancer	0.000354	0.00356	CcSEcCtD
Eprosartan—Urticaria—Procarbazine—brain cancer	0.000353	0.00355	CcSEcCtD
Eprosartan—Tinnitus—Temozolomide—brain cancer	0.000352	0.00354	CcSEcCtD
Eprosartan—Body temperature increased—Procarbazine—brain cancer	0.000351	0.00353	CcSEcCtD
Eprosartan—Abdominal pain—Procarbazine—brain cancer	0.000351	0.00353	CcSEcCtD
Eprosartan—Chills—Temozolomide—brain cancer	0.000339	0.00341	CcSEcCtD
Eprosartan—Thrombocytopenia—Hydroxyurea—brain cancer	0.000336	0.00338	CcSEcCtD
Eprosartan—Renal failure—Etoposide—brain cancer	0.000331	0.00333	CcSEcCtD
Eprosartan—Neuropathy peripheral—Etoposide—brain cancer	0.00033	0.00332	CcSEcCtD
Eprosartan—Back pain—Carmustine—brain cancer	0.000329	0.00331	CcSEcCtD
Eprosartan—Anorexia—Hydroxyurea—brain cancer	0.000327	0.00329	CcSEcCtD
Eprosartan—Hypersensitivity—Procarbazine—brain cancer	0.000327	0.00329	CcSEcCtD
Eprosartan—Tremor—Carmustine—brain cancer	0.000319	0.00321	CcSEcCtD
Eprosartan—Asthenia—Procarbazine—brain cancer	0.000318	0.0032	CcSEcCtD
Eprosartan—Back pain—Temozolomide—brain cancer	0.000318	0.0032	CcSEcCtD
Eprosartan—Pruritus—Procarbazine—brain cancer	0.000314	0.00316	CcSEcCtD
Eprosartan—Tremor—Temozolomide—brain cancer	0.000308	0.0031	CcSEcCtD
Eprosartan—Dyspnoea—Hydroxyurea—brain cancer	0.000306	0.00308	CcSEcCtD
Eprosartan—Somnolence—Hydroxyurea—brain cancer	0.000305	0.00307	CcSEcCtD
Eprosartan—Ill-defined disorder—Temozolomide—brain cancer	0.000305	0.00307	CcSEcCtD
Eprosartan—Diarrhoea—Procarbazine—brain cancer	0.000304	0.00305	CcSEcCtD
Eprosartan—Dyspepsia—Hydroxyurea—brain cancer	0.000302	0.00304	CcSEcCtD
Eprosartan—Angioedema—Temozolomide—brain cancer	0.0003	0.00302	CcSEcCtD
Eprosartan—Decreased appetite—Hydroxyurea—brain cancer	0.000299	0.003	CcSEcCtD
Eprosartan—Malaise—Temozolomide—brain cancer	0.000297	0.00298	CcSEcCtD
Eprosartan—Fatigue—Hydroxyurea—brain cancer	0.000296	0.00298	CcSEcCtD
Eprosartan—Vertigo—Temozolomide—brain cancer	0.000295	0.00297	CcSEcCtD
Eprosartan—Pain—Hydroxyurea—brain cancer	0.000294	0.00295	CcSEcCtD
Eprosartan—Constipation—Hydroxyurea—brain cancer	0.000294	0.00295	CcSEcCtD
Eprosartan—Dizziness—Procarbazine—brain cancer	0.000294	0.00295	CcSEcCtD
Eprosartan—Palpitations—Temozolomide—brain cancer	0.000291	0.00292	CcSEcCtD
Eprosartan—Myalgia—Carmustine—brain cancer	0.00029	0.00291	CcSEcCtD
Eprosartan—Chest pain—Carmustine—brain cancer	0.00029	0.00291	CcSEcCtD
Eprosartan—Anxiety—Carmustine—brain cancer	0.000289	0.0029	CcSEcCtD
Eprosartan—Cough—Temozolomide—brain cancer	0.000287	0.00289	CcSEcCtD
Eprosartan—Feeling abnormal—Hydroxyurea—brain cancer	0.000283	0.00285	CcSEcCtD
Eprosartan—Vomiting—Procarbazine—brain cancer	0.000282	0.00284	CcSEcCtD
Eprosartan—Myalgia—Temozolomide—brain cancer	0.00028	0.00282	CcSEcCtD
Eprosartan—Arthralgia—Temozolomide—brain cancer	0.00028	0.00282	CcSEcCtD
Eprosartan—Rash—Procarbazine—brain cancer	0.00028	0.00281	CcSEcCtD
Eprosartan—Dermatitis—Procarbazine—brain cancer	0.00028	0.00281	CcSEcCtD
Eprosartan—Anxiety—Temozolomide—brain cancer	0.000279	0.00281	CcSEcCtD
Eprosartan—Headache—Procarbazine—brain cancer	0.000278	0.0028	CcSEcCtD
Eprosartan—Discomfort—Temozolomide—brain cancer	0.000277	0.00278	CcSEcCtD
Eprosartan—Dry mouth—Temozolomide—brain cancer	0.000274	0.00275	CcSEcCtD
Eprosartan—Thrombocytopenia—Carmustine—brain cancer	0.000272	0.00273	CcSEcCtD
Eprosartan—Body temperature increased—Hydroxyurea—brain cancer	0.000272	0.00273	CcSEcCtD
Eprosartan—Chills—Etoposide—brain cancer	0.000271	0.00273	CcSEcCtD
Eprosartan—Tachycardia—Carmustine—brain cancer	0.000271	0.00273	CcSEcCtD
Eprosartan—Anorexia—Carmustine—brain cancer	0.000265	0.00266	CcSEcCtD
Eprosartan—Nausea—Procarbazine—brain cancer	0.000264	0.00265	CcSEcCtD
Eprosartan—Thrombocytopenia—Temozolomide—brain cancer	0.000263	0.00264	CcSEcCtD
Eprosartan—Hypotension—Carmustine—brain cancer	0.00026	0.00261	CcSEcCtD
Eprosartan—Hyperhidrosis—Temozolomide—brain cancer	0.000259	0.00261	CcSEcCtD
Eprosartan—Anorexia—Temozolomide—brain cancer	0.000256	0.00257	CcSEcCtD
Eprosartan—Back pain—Etoposide—brain cancer	0.000255	0.00256	CcSEcCtD
Eprosartan—Hypersensitivity—Hydroxyurea—brain cancer	0.000253	0.00255	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Carmustine—brain cancer	0.000253	0.00254	CcSEcCtD
Eprosartan—Muscle spasms—Etoposide—brain cancer	0.000253	0.00254	CcSEcCtD
Eprosartan—Insomnia—Carmustine—brain cancer	0.000251	0.00253	CcSEcCtD
Eprosartan—Paraesthesia—Carmustine—brain cancer	0.000249	0.00251	CcSEcCtD
Eprosartan—Dyspnoea—Carmustine—brain cancer	0.000248	0.00249	CcSEcCtD
Eprosartan—Somnolence—Carmustine—brain cancer	0.000247	0.00248	CcSEcCtD
Eprosartan—Asthenia—Hydroxyurea—brain cancer	0.000246	0.00248	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000245	0.00246	CcSEcCtD
Eprosartan—Ill-defined disorder—Etoposide—brain cancer	0.000244	0.00246	CcSEcCtD
Eprosartan—Insomnia—Temozolomide—brain cancer	0.000243	0.00244	CcSEcCtD
Eprosartan—Decreased appetite—Carmustine—brain cancer	0.000241	0.00243	CcSEcCtD
Eprosartan—Paraesthesia—Temozolomide—brain cancer	0.000241	0.00242	CcSEcCtD
Eprosartan—Dyspnoea—Temozolomide—brain cancer	0.000239	0.00241	CcSEcCtD
Eprosartan—Somnolence—Temozolomide—brain cancer	0.000239	0.0024	CcSEcCtD
Eprosartan—Constipation—Carmustine—brain cancer	0.000237	0.00239	CcSEcCtD
Eprosartan—Pain—Carmustine—brain cancer	0.000237	0.00239	CcSEcCtD
Eprosartan—Malaise—Etoposide—brain cancer	0.000237	0.00239	CcSEcCtD
Eprosartan—Vertigo—Etoposide—brain cancer	0.000236	0.00238	CcSEcCtD
Eprosartan—Dyspepsia—Temozolomide—brain cancer	0.000236	0.00238	CcSEcCtD
Eprosartan—Diarrhoea—Hydroxyurea—brain cancer	0.000235	0.00236	CcSEcCtD
Eprosartan—Decreased appetite—Temozolomide—brain cancer	0.000233	0.00235	CcSEcCtD
Eprosartan—Fatigue—Temozolomide—brain cancer	0.000231	0.00233	CcSEcCtD
Eprosartan—Loss of consciousness—Etoposide—brain cancer	0.000231	0.00233	CcSEcCtD
Eprosartan—Cough—Etoposide—brain cancer	0.00023	0.00231	CcSEcCtD
Eprosartan—Constipation—Temozolomide—brain cancer	0.00023	0.00231	CcSEcCtD
Eprosartan—Pain—Temozolomide—brain cancer	0.00023	0.00231	CcSEcCtD
Eprosartan—Feeling abnormal—Carmustine—brain cancer	0.000229	0.0023	CcSEcCtD
Eprosartan—Dizziness—Hydroxyurea—brain cancer	0.000227	0.00228	CcSEcCtD
Eprosartan—Gastrointestinal pain—Carmustine—brain cancer	0.000227	0.00228	CcSEcCtD
Eprosartan—Chest pain—Etoposide—brain cancer	0.000224	0.00225	CcSEcCtD
Eprosartan—Discomfort—Etoposide—brain cancer	0.000221	0.00223	CcSEcCtD
Eprosartan—Feeling abnormal—Temozolomide—brain cancer	0.000221	0.00222	CcSEcCtD
Eprosartan—Abdominal pain—Carmustine—brain cancer	0.00022	0.00221	CcSEcCtD
Eprosartan—Body temperature increased—Carmustine—brain cancer	0.00022	0.00221	CcSEcCtD
Eprosartan—Gastrointestinal pain—Temozolomide—brain cancer	0.000219	0.00221	CcSEcCtD
Eprosartan—Vomiting—Hydroxyurea—brain cancer	0.000218	0.0022	CcSEcCtD
Eprosartan—Rash—Hydroxyurea—brain cancer	0.000217	0.00218	CcSEcCtD
Eprosartan—Dermatitis—Hydroxyurea—brain cancer	0.000216	0.00218	CcSEcCtD
Eprosartan—Headache—Hydroxyurea—brain cancer	0.000215	0.00216	CcSEcCtD
Eprosartan—Urticaria—Temozolomide—brain cancer	0.000213	0.00214	CcSEcCtD
Eprosartan—Abdominal pain—Temozolomide—brain cancer	0.000212	0.00213	CcSEcCtD
Eprosartan—Body temperature increased—Temozolomide—brain cancer	0.000212	0.00213	CcSEcCtD
Eprosartan—Thrombocytopenia—Etoposide—brain cancer	0.00021	0.00211	CcSEcCtD
Eprosartan—Tachycardia—Etoposide—brain cancer	0.00021	0.00211	CcSEcCtD
Eprosartan—Hyperhidrosis—Etoposide—brain cancer	0.000208	0.00209	CcSEcCtD
Eprosartan—Anorexia—Etoposide—brain cancer	0.000205	0.00206	CcSEcCtD
Eprosartan—Hypersensitivity—Carmustine—brain cancer	0.000205	0.00206	CcSEcCtD
Eprosartan—Nausea—Hydroxyurea—brain cancer	0.000204	0.00205	CcSEcCtD
Eprosartan—Hypotension—Etoposide—brain cancer	0.000201	0.00202	CcSEcCtD
Eprosartan—Asthenia—Carmustine—brain cancer	0.000199	0.002	CcSEcCtD
Eprosartan—Hypersensitivity—Temozolomide—brain cancer	0.000198	0.00199	CcSEcCtD
Eprosartan—Paraesthesia—Etoposide—brain cancer	0.000193	0.00194	CcSEcCtD
Eprosartan—Asthenia—Temozolomide—brain cancer	0.000193	0.00194	CcSEcCtD
Eprosartan—Dyspnoea—Etoposide—brain cancer	0.000191	0.00193	CcSEcCtD
Eprosartan—Somnolence—Etoposide—brain cancer	0.000191	0.00192	CcSEcCtD
Eprosartan—Diarrhoea—Carmustine—brain cancer	0.00019	0.00191	CcSEcCtD
Eprosartan—Pruritus—Temozolomide—brain cancer	0.00019	0.00191	CcSEcCtD
Eprosartan—Decreased appetite—Etoposide—brain cancer	0.000187	0.00188	CcSEcCtD
Eprosartan—Fatigue—Etoposide—brain cancer	0.000185	0.00186	CcSEcCtD
Eprosartan—Dizziness—Carmustine—brain cancer	0.000184	0.00185	CcSEcCtD
Eprosartan—Constipation—Etoposide—brain cancer	0.000184	0.00185	CcSEcCtD
Eprosartan—Pain—Etoposide—brain cancer	0.000184	0.00185	CcSEcCtD
Eprosartan—Diarrhoea—Temozolomide—brain cancer	0.000184	0.00185	CcSEcCtD
Eprosartan—Dizziness—Temozolomide—brain cancer	0.000177	0.00178	CcSEcCtD
Eprosartan—Feeling abnormal—Etoposide—brain cancer	0.000177	0.00178	CcSEcCtD
Eprosartan—Vomiting—Carmustine—brain cancer	0.000177	0.00178	CcSEcCtD
Eprosartan—Gastrointestinal pain—Etoposide—brain cancer	0.000176	0.00177	CcSEcCtD
Eprosartan—Rash—Carmustine—brain cancer	0.000175	0.00176	CcSEcCtD
Eprosartan—Dermatitis—Carmustine—brain cancer	0.000175	0.00176	CcSEcCtD
Eprosartan—Headache—Carmustine—brain cancer	0.000174	0.00175	CcSEcCtD
Eprosartan—Vomiting—Temozolomide—brain cancer	0.000171	0.00172	CcSEcCtD
Eprosartan—Urticaria—Etoposide—brain cancer	0.000171	0.00172	CcSEcCtD
Eprosartan—Abdominal pain—Etoposide—brain cancer	0.00017	0.00171	CcSEcCtD
Eprosartan—Body temperature increased—Etoposide—brain cancer	0.00017	0.00171	CcSEcCtD
Eprosartan—Rash—Temozolomide—brain cancer	0.000169	0.0017	CcSEcCtD
Eprosartan—Dermatitis—Temozolomide—brain cancer	0.000169	0.0017	CcSEcCtD
Eprosartan—Headache—Temozolomide—brain cancer	0.000168	0.00169	CcSEcCtD
Eprosartan—Nausea—Carmustine—brain cancer	0.000165	0.00166	CcSEcCtD
Eprosartan—Nausea—Temozolomide—brain cancer	0.000159	0.0016	CcSEcCtD
Eprosartan—Hypersensitivity—Etoposide—brain cancer	0.000158	0.00159	CcSEcCtD
Eprosartan—Asthenia—Etoposide—brain cancer	0.000154	0.00155	CcSEcCtD
Eprosartan—Pruritus—Etoposide—brain cancer	0.000152	0.00153	CcSEcCtD
Eprosartan—Diarrhoea—Etoposide—brain cancer	0.000147	0.00148	CcSEcCtD
Eprosartan—Dizziness—Etoposide—brain cancer	0.000142	0.00143	CcSEcCtD
Eprosartan—Vomiting—Etoposide—brain cancer	0.000137	0.00137	CcSEcCtD
Eprosartan—Rash—Etoposide—brain cancer	0.000135	0.00136	CcSEcCtD
Eprosartan—Dermatitis—Etoposide—brain cancer	0.000135	0.00136	CcSEcCtD
Eprosartan—Headache—Etoposide—brain cancer	0.000135	0.00135	CcSEcCtD
Eprosartan—Nausea—Etoposide—brain cancer	0.000128	0.00128	CcSEcCtD
